Inhibitors targeting the functional activity of C5orf54 exploit various cellular mechanisms to exert their effects. For instance, some inhibitors act on prominent signaling pathways such as the mTOR pathway, which is essential for regulating cellular growth and metabolism. These inhibitors form complexes with intracellular proteins that specifically downregulate the function of mTOR, leading to a subsequent decrease in the activity of C5orf54 due to its association with mTOR signaling. Other inhibitors directly target the PI3K/Akt/mTOR cascade, a crucial signaling axis in cell survival and proliferation, which when obstructed, results in the attenuation of C5orf54 activity. Additionally, compounds that inhibit glucose metabolism can also impact the functional activity of C5orf54 by limiting the essential energy supply and biosynthetic precursors, suggesting a link between C5orf54 and cellular metabolic processes.
Another set of inhibitors focuses on the MAPK/ERK and p38 MAPK pathways, which are integral in cell differentiation, growth, and response to stress. By inhibiting the upstream kinases in these pathways, the activity of C5orf54 can be indirectly reduced if it acts as a downstream effector. Inhibitors of the JNK signaling pathway further contribute to the modulation of C5orf54 by targeting stress response mechanisms. Moreover, proteasome inhibitors can lead to an overall decrease in the levels of C5orf54 through the enhanced degradation of misfolded proteins, suggesting a role for C5orf54 in protein quality control. Disrupting the Hedgehog signaling pathway or interfering with calcium homeostasis by SERCA pump inhibitors could also indirectly reduce C5orf54 activity, pointing to its possible involvement in these cellular processes. Lastly, inhibitors of cell cycle kinases illustrate the broad spectrum of mechanisms by which the activity of C5orf54 can be modulated, highlighting its potential integration in various cellular functions.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Inhibits mTOR by forming a complex with FKBP12, leading to the downregulation of C5orf54 due to its involvement in mTOR signaling. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
A PI3K inhibitor that impedes the PI3K/Akt/mTOR pathway, thereby reducing the activity of C5orf54 linked to this signaling cascade. | ||||||
Wiskostatin | 253449-04-6 | sc-204399 sc-204399A sc-204399B sc-204399C | 1 mg 5 mg 25 mg 50 mg | $48.00 $122.00 $432.00 $812.00 | 4 | |
Glucose transporter 1 inhibitor that impedes glycolysis, affecting C5orf54 which is related to metabolic processes. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
MEK inhibitor that disrupts the MAPK/ERK pathway, indirectly inhibiting C5orf54 if it is a downstream effector in this pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
p38 MAPK inhibitor that may decrease the functional activity of C5orf54 by inhibiting pathways where p38 MAPK is upstream. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK signaling, potentially diminishing the activity of C5orf54 if it is modulated by JNK pathway constituents. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Proteasome inhibitor that can lead to reduced levels of C5orf54 through increased degradation of misfolded proteins. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
A proteasome inhibitor that can decrease the functional activity of C5orf54 by promoting the degradation of proteins involved in its pathway. | ||||||
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $92.00 $204.00 | 19 | |
Hedgehog pathway inhibitor that could decrease the activity of C5orf54 if it is involved in the Hedgehog signaling pathway. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
SERCA pump inhibitor leading to disruption of calcium homeostasis, which could indirectly reduce C5orf54 activity if it is calcium-dependent. | ||||||